TokenPost·
Baird Downgrades Insulet to Neutral and Cuts Price Target to $158

The firm lowered its target from $200 after a survey found weaker brand loyalty to automated insulin delivery systems than in the past.
Every crypto headline. One feed. Updated every minute.

The firm lowered its target from $200 after a survey found weaker brand loyalty to automated insulin delivery systems than in the past.